-transparent.png){kind=logo}
A late phase II trial on RP 56976 (Docetaxel) was carried out against stage IIIB or IV non-resectable non-small cell lung cancer as a multicenter cooperative trial. Of 78 enrolled patients, seventy five patients were eligible and 71 were evaluable for the response. The overall response rate was 19.7% (14/71): 27.9% (12/48) of patients with adenocarcinoma and 10.0% (2/20) of patients with squamous cell carcinoma responded to docetaxel. The response rate was 15.0% (3/20) in patients with stage III B disease and 21.6% (11/51) in patients with stage IV disease. Leukopenia (neutropenia) occurred frequently, but most tended to recover in a short period of time. Other adverse reactions included nausea/vomiting, anorexia, general malaise, alopecia, all of which were not severe. Severe hypersensitivity reactions occurred in 2 patients (2.7%). The results seemed to show usefulness of docetaxel for the treatment of patients with non-small cell lung cancer.
T Onoshi, and
K Watanabe, and
K Furuse, and
Y Kurita, and
T Sugiura, and
K Sato, and
M Fujii, and
K Oizumi, and
S Abe, and
Y Inoue
November 1994,
Gan to kagaku ryoho. Cancer & chemotherapy,
T Onoshi, and
K Watanabe, and
K Furuse, and
Y Kurita, and
T Sugiura, and
K Sato, and
M Fujii, and
K Oizumi, and
S Abe, and
Y Inoue
November 1994,
Gan to kagaku ryoho. Cancer & chemotherapy,
T Onoshi, and
K Watanabe, and
K Furuse, and
Y Kurita, and
T Sugiura, and
K Sato, and
M Fujii, and
K Oizumi, and
S Abe, and
Y Inoue
March 2000,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
T Onoshi, and
K Watanabe, and
K Furuse, and
Y Kurita, and
T Sugiura, and
K Sato, and
M Fujii, and
K Oizumi, and
S Abe, and
Y Inoue
November 1996,
Anti-cancer drugs,
T Onoshi, and
K Watanabe, and
K Furuse, and
Y Kurita, and
T Sugiura, and
K Sato, and
M Fujii, and
K Oizumi, and
S Abe, and
Y Inoue
January 1996,
British journal of cancer,
T Onoshi, and
K Watanabe, and
K Furuse, and
Y Kurita, and
T Sugiura, and
K Sato, and
M Fujii, and
K Oizumi, and
S Abe, and
Y Inoue
January 2000,
Acta oncologica (Stockholm, Sweden),
T Onoshi, and
K Watanabe, and
K Furuse, and
Y Kurita, and
T Sugiura, and
K Sato, and
M Fujii, and
K Oizumi, and
S Abe, and
Y Inoue
June 1994,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
T Onoshi, and
K Watanabe, and
K Furuse, and
Y Kurita, and
T Sugiura, and
K Sato, and
M Fujii, and
K Oizumi, and
S Abe, and
Y Inoue
August 2009,
Clinical oncology (Royal College of Radiologists (Great Britain)),
T Onoshi, and
K Watanabe, and
K Furuse, and
Y Kurita, and
T Sugiura, and
K Sato, and
M Fujii, and
K Oizumi, and
S Abe, and
Y Inoue
January 1999,
Gan to kagaku ryoho. Cancer & chemotherapy,
T Onoshi, and
K Watanabe, and
K Furuse, and
Y Kurita, and
T Sugiura, and
K Sato, and
M Fujii, and
K Oizumi, and
S Abe, and
Y Inoue
December 2006,
Japanese journal of clinical oncology,
